英文名稱 | Simeprevir sodium | TMC435 sodium | TMC435350 sodium | Olysio |
---|---|
中文名稱 | 西咪匹韋鈉 |西米普韋鈉鹽 |
CAS號 | 1241946-89-3 |
分子式 | C38H47N5O7S2.XNa |
分子量 | 749.94 (free) |
英文名稱 | Simeprevir sodium | TMC435 sodium | TMC435350 sodium | Olysio |
---|---|
中文名稱 | 西咪匹韋鈉 |西米普韋鈉鹽 |
CAS號 | 1241946-89-3 |
分子式 | C38H47N5O7S2.XNa |
分子量 | 749.94 (free) |
Simeprevir (TMC435; TMC435350) sodium is an oral, potent and highly specific hepatitis C virus (HCV) NS3/4A protease inhibitor with a Ki of 0.36 nM. Simeprevir sodium inhibits HCV replication with an EC50 of 7.8 nM. Simeprevir sodium also potently suppresses SARS-CoV-2 replication and synergizes with Remdesivir. Simeprevir sodium inhibits the main protease (Mpro) and the RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2, and also modulates host immune responses.